Zoetis Inc. (ZTS)
Zoetis - Zoetis Announces Second Quarter 2026 Results
KODIAK SCIENCES INC. (KOD)
Kodiak Sciences Completes Enrollment in First Pivotal Cohort in the Phase 3 PEAK Trial of KSI-101 for Macular Edema Secondary to Inflammation and Reaffirms Topline Clinical Data Release Remains on Track for December 2026
CARTESIAN THERAPEUTICS, INC. (RNAC)
Cartesian Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
SIONNA THERAPEUTICS, INC. (SION)
Sionna Therapeutics Reports Second Quarter 2026 Financial Results
STARWOOD PROPERTY TRUST, INC. (STWD)
Starwood Property Trust Reports Results for Quarter Ended June 30, 2026
INTELLIA THERAPEUTICS, INC. (NTLA)
Intellia Therapeutics Announces Second Quarter 2026 Financial Results and Business Updates
KEURIG DR PEPPER INC. (KDP)
Keurig Dr Pepper Reports Q2 Results and Reaffirms Guidance for 2026
SOTERA HEALTH CO (SHC)
Sotera Health Delivers Strong Second-Quarter and First-Half 2026 Results and Raises FY 2026 Outlook
VIA TRANSPORTATION, INC. (VIA)
Via Announces Second Quarter 2026 Results
Zoetis Inc. (ZTS)
Zoetis Announces Second Quarter 2026 Results
OPUS GENETICS, INC. (IRD)
Opus Genetics Announces Financial Results for Second Quarter 2026 and Provides Corporate Update
SHARONAI HOLDINGS INC. (SHAZ)
Sharon AI Reports Second Quarter 2026 Results
BIOHAVEN LTD. (BHVN)
Biohaven Appoints Technology Investor John Yetimoglu to Board of Directors
AVALO THERAPEUTICS, INC. (AVTX)
Avalo Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Updates
DAQO NEW ENERGY CORP. (DQ)
Daqo New Energy to Announce Unaudited Financial Results for the Second Quarter of 2026 on August 20, 2026